Literature DB >> 11857395

Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women.

Lynya I Talley1, William E Grizzle, John W Waterbor, David Brown, Heidi Weiss, Andra R Frost.   

Abstract

Breast cancers in younger, premenopausal women are more likely to exhibit an adverse prognostic profile (including negative steroid hormone receptors and a high rate of cellular proliferation) and poor outcome than breast cancers in postmenopausal women. It has been hypothesized that this adverse prognostic profile is a result of the higher histologic grade of breast cancers in pre- compared with post-menopausal women. To assess the association of expression of steroid hormone receptors and indicators of proliferation while controlling for histologic grade, we identified 100 infiltrating ductal carcinomas from premenopausal women 45 years of age or younger and 100 from postmenopausal women 65 years of age or older. The carcinomas were selected so that the histologic grades (low versus high) were distributed equally between the 2 groups. Estrogen receptors (ER), progesterone receptors (PR), p27(Kip1) and Ki-67 (to measure rate of proliferation) were assessed by immunohistochemistry and compared between groups. Clinical information and survival data were also analyzed. ER content was lower and proliferation was higher in carcinomas in premenopausal women (p = 0.048 and p = 0.005, respectively). By univariate analysis, p27(Kip1) and PR were not different between the groups; however, in multivariate analysis, p27(Kip1) was higher in postmenopausal women, but only in a subgroup with highly proliferative carcinomas. Overall survival was similar in the pre- and postmenopausal women. Furthermore, low p27(Kip1) and African-American ethnicity predicted a poorer overall survival in the premenopausal, but not in the postmenopausal, women in our study. After controlling for histologic grade, a lower expression of ER and a higher proliferative index were detected in breast carcinomas in premenopausal women. Therefore, some prognostic indicators, such as ER and proliferative rate, may be more closely associated with menopausal status than histologic grade. Our data also suggest that some prognostic factors are not equally effective as predictors of survival in pre- and postmenopausal women. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857395     DOI: 10.1002/ijc.10171

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues.

Authors:  Kun Yuan; Natalya Frolova; Yi Xie; Dezhi Wang; Leah Cook; Yeon-Jin Kwon; Adam D Steg; Rosa Serra; Andra R Frost
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

2.  Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene.

Authors:  P V Lopes-Costa; A R dos Santos; L G dos Santos; B B da Silva
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

Review 3.  Physical activity and mammographic breast density: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz; Kathleen Wolin
Journal:  Breast Cancer Res Treat       Date:  2012-07-20       Impact factor: 4.872

Review 4.  Vitamin D and mammographic breast density: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz; Bettina Drake
Journal:  Cancer Causes Control       Date:  2011-10-08       Impact factor: 2.506

5.  Translational pathology of neoplasia.

Authors:  William E Grizzle; Sudhir Srivastava; Upender Manne
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer.

Authors:  Shibani Mukherjee; Natalya Frolova; Andrea Sadlonova; Zdenek Novak; Adam Steg; Grier P Page; Danny R Welch; Susan M Lobo-Ruppert; J Michael Ruppert; Martin R Johnson; Andra R Frost
Journal:  Cancer Biol Ther       Date:  2006-06-18       Impact factor: 4.742

7.  Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.

Authors:  Lusheng Xu; Yeon-Jin Kwon; Natalya Frolova; Adam D Steg; Kun Yuan; Martin R Johnson; William E Grizzle; Renee A Desmond; Andra R Frost
Journal:  Breast Cancer Res Treat       Date:  2009-11-10       Impact factor: 4.872

8.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

9.  Sulfotransferase 2B1b in human breast: differences in subcellular localization in African American and Caucasian women.

Authors:  Nicole A Dumas; Dongning He; Andra R Frost; Charles N Falany
Journal:  J Steroid Biochem Mol Biol       Date:  2008-06-08       Impact factor: 4.292

10.  Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications.

Authors:  Daehoon Park; Rolf Kåresen; Tove Noren; Torill Sauer
Journal:  Virchows Arch       Date:  2007-06-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.